Nanoco Refocuses on Strategic Growth
11.2.2025 13:00:00 CET | Business Wire | Press Release
Nanoco Group PLC (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other advanced nanomaterials, has completed several organisational changes designed to accelerate its commercial development.
In October 2024, Dmitry Shashkov joined as Chief Executive Officer. He has a proven 20 year plus track record in leading materials science-based businesses, driving shareholder value through transformational business development.
Dmitry was CEO of the CPS Group of companies (later part of Exyte), which focused on high-tech equipment for semiconductors and life science industries. Under his leadership, CPS revenues tripled, and profitability increased fourfold before its sale to a strategic investor. Prior to CPS, Dmitry was President and CEO of H.C. Starck Inc. (a world-leading supplier of refractory metals) and Business Director at Honeywell (a leading supplier of electronic materials). He began his career with McKinsey & Company, advising clients in the pharmaceutical, chemical, and telecommunications industries.
In December 2024, Jai Subramanian joined Nanoco as Global Business Director. With over 20 years of experience in semiconductors, specialty materials, and advanced coatings, Jai has a strong track record in global business transformation and growth, P&L management, and strategic market expansion across the USA, Europe, and Asia.
Jai joined Nanoco from Soleras Advanced Coatings, where he was General Manager for the USA and Global Business Director. Previously, he held leadership roles at H.C. Starck, Honeywell, and Ferro Corporation. With Jai’s appointment, Nanoco now has a global commercial team with a presence in East Asia, Europe, and the US. The team will be instrumental in managing customer relationships, driving partnerships, and communicating Nanoco’s value proposition to prospective customers.
Most recently, Jalal Bagherli, CBE, was appointed Chairman of the Board in January. A highly respected figure in the semiconductor industry, Jalal has worked with some of the world’s largest brands in the electronics sector. As CEO of Dialog Semiconductor, he transformed the company into a high-growth, high-value business. His contributions to the industry have been recognised with a CBE for services to technology, and he currently serves as Co-Chair of the UK Semiconductor Policy Advisory Panel.
The appointments of Dmitry Shashkov as CEO, Jai Subramanian as Global Business Director, and Jalal Bagherli, CBE, as Chairman of the Board, reinforce Nanoco’s focus on executing its commercialisation strategy. The roadmap outlined in mid-2024 positions Nanoco for growth in high-value markets, and over the past year, the company has strengthened its leadership team to drive the next phase of expansion.
Jalal Bagherli, CBE, said:
“With a world-class technology platform and a strengthened leadership team, Nanoco is now poised to deliver on its commercialisation strategy. With Dmitry and Jai on board, I look forward to seeing progress on the commercial front. We are focused on accelerating engagement with customers and investors and scaling our breakthrough quantum dot technology into high-value applications.”
Jai Subramanian said:
“Nanoco has a unique opportunity to commercialise its breakthrough quantum dot technology at scale. Its leading R&D and installed production capacity, supported by a validated IP portfolio in a fully funded business, form a rare and strong foundation. I’m excited to work alongside our global partners and customers to bring Nanoco’s technology to market and create lasting value.”
About Nanoco Group plc
Nanoco (LSE: NANO) is a nanomaterial production and licensing group, specialising in the production of its patented cadmium-free quantum dots (CFQD®) and other patented nanomaterials for use in the electronics industry. Founded in 2001 and headquartered in Runcorn, UK, Nanoco continues to build a world-class, patent-protected IP portfolio alongside its existing scaled-up production facilities for commercial orders.
For further information, please visit: www.nanocotechnologies.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211770290/en/
Contacts
Sodali & Co
nanoco@sodali.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press Release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom